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Abstract
Background Although postoperative hematoma after
thyroidectomy is uncommon, patients traditionally have
been advised to stay overnight in the hospital for moni-
toring. With the growing demand for outpatient thyroid-
ectomy, we assessed its safety and feasibility by evaluating
the potential risk factors and timing of postoperative
hematoma after thyroidectomy.
Methods From 1995–2011, 3,086 consecutive patients
underwent thyroidectomy at our institution; of these, 22
(0.7 %) developed a postoperative hematoma that required
surgical reexploration (group I). Potential risk factors were
compared between group I and those without hematoma
(n = 3,045) or with hematoma but not requiring reexplo-
ration (n = 19; group II). Variables that were significant in
the univariate analysis were entered into multivariate
analysis by binary logistic regression analysis.
Results Group I was significantly more likely to have
undergone previous thyroid operation than group II (27.3
vs. 8.2 %, p = 0.007). The median weight of excised
thyroid gland (71.8 vs. 40 g, p = 0.018) and the median
size of the dominant nodule (4.1 vs. 3 cm, p = 0.004) were
significantly greater in group I than group II. Previous
thyroid operation (odds ratio (OR) = 4.084; 95 % confi-
dence interval (CI), 1.105–15.098; p = 0.035) and size of
dominant nodule (OR = 1.315; 95 % CI, 1.024–1.687;
p = 0.032) were independent factors for hematoma. Six-
teen (72.7 %) had hematoma within 6 h, whereas the other
6 (27.3 %) had hematoma at 6–24 h.
Conclusions Previous thyroid operation and large domi-
nant nodule were independent risk factors for hematoma
requiring surgical reexploration. Given that a quarter of
hematoma occurred between 6 to 24 h after surgery, rou-
tine outpatient thyroidectomy could not be recommended.
Introduction
Thyroidectomy is not only one of the most commonly
performed surgical procedures but also one of the safest in
experienced hands [1]. The common surgical indications
include multinodular goiter with compressive symptoms,
suspicious or indeterminate nodule, proven malignancy,
relapsed Grave’s disease, and retrosternal goiter [2, 3].
Although a great deal of work has been published focusing
on the prevention and reduction of thyroidectomy-related
complications, such as recurrent laryngeal nerve injury and
postoperative hypoparathyroidism in the literature [4–6],
relatively fewer studies have focused on prevention and
risk factors of postoperative hemorrhage or hematoma after
thyroidectomy [7–10]. This might be because with
improved surgical technique and meticulous hemostasis,
clinically significant hematoma occurs uncommonly and
even when it does, if managed timely and appropriately,
patients are expected to fully recover afterwards. Never-
theless, it should be reminded that it is a potentially life-
threatening complication and in a recent territory-wide
audit of 1,616 patients in 17 local hospitals, two deaths
resulted from thyroidectomy with one directly related to
postoperative hematoma [11]. Furthermore, it would be
timely to refocus on this particular complication more
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critically, because there has been a gradual shift of practice
from inpatient to outpatient or same-day thyroidectomy
[12–14]. Despite the ongoing debate on the safety of out-
patient thyroidectomy, there is evidence to suggest that
outpatient thyroidectomy is becoming increasingly wide-
spread particularly in the United States [12, 13]. Although
we fully acknowledge the fact that hematoma formation is
only one of many issues to consider in the assessment of
outpatient thyroidectomy, nevertheless it is the most life-
threatening and deserves more critical evaluation. With this
background, the present study was designed to assess the
safety and feasibility of outpatient thyroidectomy by
evaluating the potential risk factors and timing of postop-
erative hematoma in a predominantly inpatient thyroidec-
tomy cohort.
Patients and methods
From 1995 to 2011, 3,086 consecutive patients who
underwent thyroidectomy in our institution were reviewed
retrospectively. All were operated on by two endocrine
surgeons (BHL, CYL) and managed afterwards by the
same surgical team. With the exception of six (0.2 %)
patients who were discharged on the same day, all post-
operative patients were admitted overnight and monitored
hourly for the first 12–18 h. The median hospital duration
was 2 (range 1–6) days. During the study period, 22
(0.7 %) patients were identified to have clinically signifi-
cant postoperative hemorrhage or hematoma after thy-
roidectomy (i.e., those requiring surgical reexploration;
group I). One particular patient required two surgical
reexplorations 24 h apart. For this study, only the first
reexploration was recorded. An additional 19 patients
developed hematoma but did not require surgical reexplo-
ration, because their hematoma was only discovered some
days after operation and was asymptomatic. These 19
patients were grouped into the nonhematoma group, and so
the total number of patients in this group was 3,064
(n = 3,045 ? 19; group II). All relevant clinical, labora-
tory, radiologic, and perioperative data were collected
prospectively and follow-up data were regularly updated in
a computerized database. To evaluate the potential risk
factors for postoperative hematoma formation, preopera-
tive and operative factors were compared between groups I
and II. For the calculation of the onset of postoperative
hematoma, it was taken as the time interval or difference
from the end of the procedure to the time when the
hematoma was first found by a medical or nursing staff or
noticed by the patient, whichever came first. The present
study protocol was approved by the local institutional
review board.
Surgery and postoperative care
Surgical techniques, postoperative care, and follow-up
protocol were similar throughout the study period and have
been previously described [15]. Preoperative patients were
instructed to stop antiplatelet agents at least 5 days before
the operation and to resume it on the following day. For
those taking warfarin, patients were asked to stop 4 days
before operation and to start low molecular weight heparin
(LMWH) at a therapeutic dose. LMWH was stopped
8–10 h before the operation. Thyroidectomy was per-
formed in a standardized manner under general anesthesia.
The strap muscles were separated in the midline and
retracted laterally. Both recurrent laryngeal nerves and
parathyroid glands were routinely identified and preserved.
Any devascularized parathyroid glands were immediately
minced and autoimplanted to the ipsilateral sternocleido-
mastoid muscle. Meticulous hemostasis was performed
before skin closure. Suction drain was placed selectively,
mostly for large-sized retrosternal goiters or those requir-
ing concomitant neck dissections. Since 2008, some of the
cases were performed endoscopically by the transaxillary
route (n = 80) or by the minimally invasive video-assisted
approach (MIVAT; n = 40) [16, 17]. The rest were per-
formed through the standard Kocher incision. Also since
2007, an alternate energy source, such as the Harmonic
scalpel focus (Ethicon, Cincinnati, OH) or Sonosurg
(Olympus, Japan), was used selectively for hemostasis and
cutting.
Statistical analysis
Statistical analysis was performed by v2 or Fisher’s exact
test to compare categorical variables, and Mann–Whitney
U test was used to compare continuous variables between
the two groups. Continuous variables were expressed as
medians with ranges. Variables that were significant in the
univariate analysis were entered into multivariate analysis.
Binary logistic regression analysis with a variable entrance
criterion of 0.05 or less was conducted to identify inde-
pendent risk factors for hematoma requiring surgical
reexploration. All statistical analyses were performed by
using SPSS version 18.0 (SPSS, Inc., Chicago, IL).
Results
Table 1 shows a comparison of patient baseline charac-
teristics and operative findings between groups I and II.
Baseline patient characteristics, such as age, sex, and
clinical presentation, were comparable between the two
groups. The final pathology also was comparable between
the two groups with nodular hyperplasia or multinodular
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goiter accounting for almost half of all pathologies. The
proportion of patients taking an antiplatelet agent or war-
farin before the operation was similar between the two
groups. Although the proportion of patients who received
radioiodine treatment was similar, significantly more
patients in group I had previous thyroid operations than
patients in group II (27.3 vs. 8.2 %, p = 0.007). When the
study period was divided into three time periods (I:
1995–2000; II: 2001–2006; III: 2007–2011) and they were
compared between the two groups, there was no significant
difference in the rate of hematoma requiring surgical re-
exploration. Hematomas that required surgical reexplora-
tion during the time periods I, II, and III were 6 of 751
(0.8 %), 8 of 1,167 (0.7 %), and 8 of 1,168 (0.7 %),
respectively. In terms of operative findings, the extent of
thyroidectomy (hemithyroidectomy/total or near-total thy-
roidectomy), surgical approach (open/endoscopic), hemo-
static technique (clamp and tie/alternate energy source),
total operating time, and drain placement were comparable
between the two groups. However, group I had signifi-
cantly heavier excised thyroid gland (71.8 vs. 40 g,
p = 0.018) and larger-sized dominant nodule (4.1 vs.
3.0 cm, p = 0.004) than group II.
Table 2 shows a multivariable analysis of potential risk
factors for hematoma requiring exploration. Variables that
were significant in the univariate analysis were entered into
the multivariate analysis. History of previous thyroid
operation (odds ratio (OR) = 4.084; 95 % confidence
interval (CI), 1.105–15.098; p = 0.035) and size of dom-
inant nodule (OR = 1.315; 95 % CI, 1.024–1.687;
p = 0.032) were the independent factors for hematoma
formation requiring surgical reexploration. Because weight
of excised gland and size of dominant nodule were some-
Table 1 Comparison of patient demographics and operative findings
between those requiring exploration of hematoma (group I) and those
either with no hematoma or not requiring exploration of hematoma
(group II)
Group I
(n = 22)
Group II
(n = 3,064)
p Value
Age at operation
(years)
52.5 (14.4–74) 48 (6–91.1) 0.34
Sex 0.161
Male 7 (31.8) 562 (18.3)
Female 15 (68.2) 2502 (81.7)
Presented with pressure
symptoms
8 (36.4) 782 (25.5) 0.213
Primary pathology
Nodular hyperplasia/
MNG
10 (45.5) 1324 (43.2) 0.217
Grave’s disease 4 (18.2) 411 (13.4) 0.525
Malignancy 3 (13.6) 551 (18) 1
Miscellaneous 5 (22.7) 778 (25.4) 0.512
On an antiplatelet agent 1 (4.5) 107 (3.5) 0.545
On warfarin 0 (0) 15 (0.5) 1
Previous thyroid
operation
6 (27.3) 251 (8.2) 0.007
Previous radioiodine
treatment
0 (0) 22 (0.7) 1
Period of operation 0.949
1995–2000 6 (27.3) 745 (24.3)
2001–2006 8 (36.4) 1159 (37.8)
2007–2011 8 (36.4) 1160 (37.9)
Extent of
thyroidectomy
0.81
Hemithyroidectomy 8 (36.4) 968 (31.6)
Total or near-total
thyroidectomy
14 (63.6) 2096 (68.4)
Surgical approach 0.646
Open 22 (100) 2947 (96.2)
Endoscopic 0 (0) 117 (3.8)
Hemostatic technique 1
Clamp and tie 21 (95.5) 2891 (94.4)
Alternate energy
source
1 (4.5) 173 (5.6)
Total operating time
(min)
120 (45–190) 113 (35–420) 0.843
Weight of excised
gland (g)
71.8 (9–152) 40 (1.8–727) 0.018
Size of dominant
nodule (cm)
4.1 (1.2–8.3) 3 (0.5–15) 0.004
Drain placement 7 (31.8) 828 (27) 0.47
Continuous variables are expressed as median (range); categorical
variables are expressed as number (percentage)
MNG multinodular goiter
Bold signifies p-value \ 0.05
Table 2 Multivariable analysis of risk factors for hematoma requir-
ing exploration (n = 22)
Covariates b-Coefficient Odds ratio
(95 % confidence
interval)
p Value
Previous thyroid operation
No 1
Yes 1.407 4.084 (1.105–15.098) 0.035
Weight of excised
gland (g)
0.001 1 (0.992–1.009) 0.911
Size of dominant
nodule (cm)a
0.273 1.315 (1.024–1.687) 0.032
a When entered as a categorical variable with 3 cm being the cutoff,
the odds ratio for size of dominant nodule [3 cm became 4.537
(95 % CI, 1.217–16.917; p = 0.024) and the odds ratio for previous
thyroid operation became 3.835 (95 % CI, 1.034–14.216; p = 0.044)
Bold signifies p-value \ 0.05
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what interrelated, each of these covariates was entered
separately with history of previous thyroid resection, but
the final results were similar to when all three covariates
were entered together. When the covariate, size of domi-
nant nodule, was converted into a binary variable using
3 cm (the median) as the cutoff and entered into the model,
relative to size B3 cm, size of dominant nodule[3 cm had
an OR of 4.54 (95 % CI, 1.22–16.92; p = 0.024).
Figure 1 shows the distribution of time interval from
end of operation to the onset of hematoma. The median
onset of hematoma was 3 h (range\1 to 24) hours. Ten of
the 22 (45.5 %) patients were found to have hematoma at
the recovery room. When patients were categorized
according to the specific time intervals (\6, 6–24, and
[24 h), 16 of 22 (72.7 %) had hematoma within 6 h,
whereas the other 6 (27.3 %) had hematoma between 6 to
24 h. No patient developed hematoma requiring reexplo-
ration after 24 h.
Risk factors for nonoperative hematoma (i.e., not
requiring reexploration) also were determined by compar-
ing patient baseline characteristics and operative findings
between those who had no hematoma (n = 3,045) and
those who had nonoperative hematoma (n = 19). Male sex
was the only significant factor for predicting nonoperative
hematoma with OR = 3.27 (95 % CI, 1.31–8.2;
p = 0.011). Factors, such as history of previous thyroid
resection, weight of excised gland, and size of dominant
nodule were not found to be significant.
Discussion
Thyroidectomy remains one of the most commonly per-
formed surgical procedures with a low morbidity rate in
experienced hands [1, 11]. Hematoma formation after thy-
roidectomy is a well-known complication, but with
improved surgical technique and meticulous hemostasis, it
has become a rare occurrence [13]. Nevertheless, if not
detected early and managed properly, it is potentially life-
threatening. In a recent territory-wide audit of 17 local hos-
pitals, at least one postoperative death was attributed to
postoperative hemorrhage [11]. In our series, the overall rate
of hematoma was 0.7 %; this rate appeared to be relatively
unchanged throughout the study period (p = 0.949). This
rate also appeared to be consistent with most other single-
institution series but lower than many multicenter or
nationwide series [7–10, 13, 18–22]. This could be attributed
to the fact that all the operations were performed by two
endocrine surgeons whose surgical practice predominantly
involved thyroidectomy. Given the possible correlation
between rate of hematoma and case volume, perhaps a
slightly higher rate of hematoma would be expected in less
specialized units [21].
One of the main purposes of conducting this study was
to evaluate whether outpatient thyroidectomy was safe and
feasible in our setting, because in our experience, the
possibility of hematoma formation remains one of the
major reasons for keeping patients overnight after surgery.
Although there are other conditions, such as postoperative
emesis, acute retention of urine, and symptomatic hypo-
calcemia, which may occur in early postoperative period
and may favor inpatient instead of outpatient procedure,
most of these are not life-threatening and could be greatly
minimized with early administration of medication and
supplementation [13, 23]. It was stimulating to see that in
one of largest outpatient thyroidectomy series, up to 86 %
of all cases were performed in an outpatient setting [13]. In
the era of cost containment, it is expected that this would
continue and become more widespread across the United
States [12, 13, 23]. According to our own territory-wide
data, outpatient thyroidectomy only accounted for 3.5 % of
all cases and so potentially there are still many patients
eligible for outpatient thyroidectomy [11]. Given this
background, our study was divided into two parts. The first
part was to determine risk factors for clinically significant
hematoma. To our knowledge, although most studies could
not identify any clear risk factors for hematoma, a few
studies reported that older age, male gender, thyroid
malignancy, and greater extent of surgery as possible risk
factors [7–10, 18–22]. However, none of four factors were
significant in our univariate and multivariate analyses.
Instead, history of previous thyroid operation and size of
dominant nodule were identified as independent risk fac-
tors for hematoma. For the latter factor, those with size of
dominant nodule [3 cm had an OR of 4.54 (95 % CI,
1.22–16.92; p = 0.024) or approximately 4.5 times higher
risk than that of size B3 cm. We postulate that the larger
Fig. 1 Distribution of time interval from initial operation to onset of
hematoma of the 22 patients requiring surgical reexploration
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size nodule tended to result in larger dissection and raw
surfaces, which might have led to increased rate of
hematoma. However, despite this postulation, it was
interesting to note that the hematoma rate between hemi-
thyroidectomy and total thyroidectomy were not different
(p = 0.81). The alternative explanation might be related to
the relatively large volume of potential dead space, which
tends to encourage hematoma formation. Although selec-
tive placement of suction drain may theoretically reduce
the volume of dead space and hematoma, our data did not
support this [24]. Regarding previous thyroid operation as
risk factor, we postulate that perhaps due to the greater
amount of scar tissue present in the reoperated field, it
would have been more difficult for the dead space after
thyroidectomy to collapse by itself and for smaller vessels
to vasoconstrict and these might contribute to the risk of
hematoma. However, it was interesting to note that none of
these factors were risk factors for the nonoperative hema-
toma group. In fact, male sex was the only risk factor.
During the study period, these 19 patients with nonopera-
tive hematoma were simply managed expectantly and
followed up weekly in our clinic until the hematoma
resolved. In our experience, their hematoma spontaneously
resolved during a period of 4–6 weeks.
The second part of our analysis focused on the timing or
onset of hematoma. Similar to previous studies, we found
that the majority (72.7 %) of hematomas requiring reex-
ploration occurred within the first 6 h after thyroidectomy
[25]. In this series, the median onset of hematoma was 3
(range \1 to 24) hours with ten (45.5 %) patients noted
with hematoma in the recovery room. Six hours was used
as the cutoff because in the outpatient setting, patients
would be monitored for approximately 6 h before dis-
charge from the hospital [7, 8]. Therefore, hypothetically,
most, if not all, of these hematomas would be detected and
managed appropriately in the day-surgery clinic. However,
the most concerning issue was that hematomas of six
(27.3 %) patients were detected after 6–24 h. If these had
been performed as outpatient procedures, the patients
would have been discharged from the hospital. In our
opinion, although this select group may only constitute 6 of
3,086 or 0.19 % of the whole cohort, if their hematoma was
not managed appropriately outside the hospital setting,
their hematoma would cause a potentially life-threatening
airway compromise or obstruction and possibly lead to a
preventable death. In fact, based on a similar conception,
Schwartz et al. calculated that 94 hematoma-related deaths
per 100,000 thyroidectomies could be prevented if patients
are monitored for 24 h instead of 6 h. If a similar calcu-
lation was performed for this study, the number of pre-
ventable hematoma-related deaths for 24-h monitoring as
opposed to 6-h monitoring would have been 194. Although
a selective approach to outpatient thyroidectomy based on
risk factors (e.g., those with no previous thyroid operation
and/or with B3 cm dominant nodule) might seem realisti-
cally possible, in our opinion, there was still going to be a
very small possibility that providing less than 24-h post-
operative monitoring could lead to a preventable hema-
toma-related death.
Despite our findings, the total number of hematomas
was relatively small, which limited the power of our study
to identify smaller effects. Therefore, we could not rule out
other possible risk factors for hematoma. Also, the present
analysis was potentially subjected to a degree of institution
and referral biases, because our center is an academic
tertiary care institute to which more complex cases often
are referred from other hospitals. A future, multicenter
study involving other institutions in our territory would be
desirable to further confirm our findings.
Conclusions
Our incidence of clinically significant hematoma formation
after thyroidectomy was 0.7 %, and this rate remained rel-
atively unchanged throughout the past 16 years. History of
previous thyroid operation and large ([3 cm) dominant
nodule were identified as independent risk factors for
hematoma formation after thyroidectomy. The majority
(72.7 %) of hematomas developed within 6 h after thyroid-
ectomy, whereas the rest (27.3 %) developed between 6 to
24 h. Given the fact that some of these hematomas may occur
up to 24 h after surgery, routine outpatient or same-day
thyroidectomy could not be recommended in our setting.
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